Related Experiment Video

Updated: May 6, 2026

A Battery of Motor Tests in a Neonatal Mouse Model of Cerebral Palsy
10:02

A Battery of Motor Tests in a Neonatal Mouse Model of Cerebral Palsy

Published on: November 3, 2016

26.2K

Pediatricians' attitude about the use of infant walkers

Semra Kara, Ayşe Esra Yilmaz, Derya Gümüş Dogan

    Archivos Argentinos De Pediatria
    |November 8, 2013
    PubMed

    Insights

    Most pediatricians do not recommend infant walkers due to injury risks. Pediatricians who treated walker-related injuries were less likely to recommend them, with many supporting a ban.

    Area of Science:

    • Pediatrics
    • Public Health

    Background:

    • Infant walkers remain popular despite potential injury risks.
    • Pediatrician attitudes towards infant walker use are not well-documented.

    Purpose of the Study:

    • To investigate pediatricians' approaches and attitudes regarding infant walker use.
    • To assess the correlation between prior treatment of walker-related injuries and recommendations.

    Main Methods:

    • A questionnaire survey was administered to 226 pediatricians at a Turkish Congress.
    • Data collected included demographics, walker recommendation practices, and experience with walker-related injuries.

    Main Results:

    • Only 4% of pediatricians recommended infant walkers.
    • 63.7% of pediatricians did not recommend walkers, while 32.2% deferred to parental judgment.
    • Pediatricians who had treated infant walker injuries were significantly less likely to recommend walkers and more likely to support a ban.

    Conclusions:

    • The majority of surveyed pediatricians do not recommend infant walkers, especially those with experience treating related injuries.
    • A significant portion of pediatricians support banning the sale and manufacture of infant walkers due to safety concerns.
    Abstract

    More Related Videos

    Quantified Assessment of Infant's Gross Motor Abilities Using a Multisensor Wearable09:24

    Quantified Assessment of Infant's Gross Motor Abilities Using a Multisensor Wearable

    Published on: May 17, 2024

    2.8K
    Using a Virtual Reality Walking Simulator to Investigate Pedestrian Behavior06:38

    Using a Virtual Reality Walking Simulator to Investigate Pedestrian Behavior

    Published on: June 9, 2020

    4.3K

    Related Concept Videos

    Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

    Pharmacokinetics in Pediatric Patients: Drug Excretion

    In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
    413
    Drug Dosing: Infants and Children01:29

    Drug Dosing: Infants and Children

    Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
    1.0K
    Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

    Pharmacokinetics in Pediatric Patients: Drug Metabolism

    In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
    414